New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 11, 2013
05:55 EDTAMED, AMED, BONT, BONT, COST, COST, KERX, KERX, RAVN, RAVN, SYPR, SYPRCompanies reporting Before the Market Open on Tuesday, March 12
Notable companies reporting before the opening bell on Tuesday include Amedisys (AMED), Bon-Ton Stores (BONT), Costco Wholesale (COST), Keryx Biopharmaceuticals (KERX), Raven Industries (RAVN), and Sypris Solutions (SYPR).
News For AMED;BONT;COST;KERX;RAVN;SYPR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 4, 2015
07:17 EDTKERXKeryx reports Q1 EPS (28c), consensus (30c)
Subscribe for More Information
May 1, 2015
16:49 EDTCOSTJ&J says Costco filed complaint against Vision Care unit
Subscribe for More Information
April 29, 2015
07:10 EDTAMEDAmedisys reports Q1 continuing ops EPS 30c, consensus 20c
Reports Q1 revenue $301.6M, consensus $300.17M.
April 27, 2015
06:15 EDTCOSTWal-Mart fighting for right to sell more alcohol in Texas, WSJ reports
Wal-Mart (WMT) is fighting for the right to sell more alcohol in Texas, The Wall Street Journal reports. The retailer is suing the Texas Alcoholic Beverage Commission, claiming legal limits on sales of hard liquor are "unconstitutional," the publication says. Wal-Mart has also joined fellow retailers Costco (COST) and Kroger (KR), as well as other groups, to back legislation that would override the current state beverage laws. Reference Link
April 23, 2015
09:35 EDTCOSTActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL FB PBR TWTR AA COST TSLA AMZN TXN BAC
08:08 EDTKERXKeryx appoints John Neylan, MD, as Chief Medical Officer
Keryx Biopharmaceuticals announced the appointment of John Neylan, MD to the newly created position of Chief Medical Officer. In this role, Dr. Neylan will be responsible for oversight of medical affairs, clinical development and pharmacovigilence at Keryx. Dr. Neylan comes to Keryx from Genzyme, where since 2008 he served in the capacity of SVP, Clinical Development, focusing on specialty metabolic diseases.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use